Greenwich Lifesciences Stock Number Of Employees
| GLSI Stock | USD 12.71 0.55 4.52% |
Greenwich Lifesciences fundamentals help investors to digest information that contributes to Greenwich Lifesciences' financial success or failures. It also enables traders to predict the movement of Greenwich Stock. The fundamental analysis module provides a way to measure Greenwich Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenwich Lifesciences stock.
Greenwich |
Greenwich Lifesciences Company Number Of Employees Analysis
Greenwich Lifesciences' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Greenwich Lifesciences Number Of Employees | 3 |
Most of Greenwich Lifesciences' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenwich Lifesciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Greenwich Lifesciences is currently employing 3.0 people. This is 99.97% lower than that of the Biotechnology sector and 99.44% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.98% higher than that of the company.
Greenwich Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenwich Lifesciences' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Greenwich Lifesciences could also be used in its relative valuation, which is a method of valuing Greenwich Lifesciences by comparing valuation metrics of similar companies.Greenwich Lifesciences is currently under evaluation in number of employees category among its peers.
Greenwich Fundamentals
| Return On Equity | -1.24 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 163.35 M | ||||
| Shares Outstanding | 13.14 M | ||||
| Shares Owned By Insiders | 52.92 % | ||||
| Shares Owned By Institutions | 8.69 % | ||||
| Number Of Shares Shorted | 556.7 K | ||||
| Price To Book | 33.95 X | ||||
| EBITDA | (9.32 M) | ||||
| Net Income | (8.89 M) | ||||
| Cash And Equivalents | 15.64 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 294.41 K | ||||
| Current Ratio | 65.74 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (6.48 M) | ||||
| Short Ratio | 21.41 X | ||||
| Earnings Per Share | (0.81) X | ||||
| Target Price | 38.0 | ||||
| Beta | 3.32 | ||||
| Market Capitalization | 159.84 M | ||||
| Total Asset | 6.99 M | ||||
| Retained Earnings | (50.36 M) | ||||
| Working Capital | 6.7 M | ||||
| Net Asset | 6.99 M |
About Greenwich Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Greenwich Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenwich Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenwich Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:Check out Greenwich Lifesciences Piotroski F Score and Greenwich Lifesciences Altman Z Score analysis. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.